RESMED INC — Director's Dealing 2010

Feb 19, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-02-17

Reporting Person: Sandercock Brett (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-02-17	ResMed Common Stock	M	20000	$38.50	Acquired	28435.439	Direct
2010-02-17	ResMed Common Stock	S	20000	$55.75	Disposed	8435.439	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-02-17	ResMed Common Stock Options	$38.50	M	20000	Disposed	2016-02-03	ResMed Common Stock (20000)	Direct

Footnotes

F1: Represents first date options became exercisable.

F2: Previous reports aggregated all beneficially owned derivative securities following the reported transaction. This report includes only beneficially owned derivative securities of the same class as those disposed of in this trade, meaning those that have the same grant date and exercise price.